The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

If you're one of the many people who have been interested in Ozempic-style weight loss medications but are terrified of ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, U ...

for Zepbound® (tirzepatide) single-dose vials to simplify prescription access. The arrangement will streamline access to the vials for clinically-eligible Nurx patients with an on-label ...

In March, Novo Nordisk began offering cash-paying customers a price of $499. Lilly also lowered the prices of several doses of Zepbound (tirzepatide) for patients purchasing the obesity medication ...

Lilly’s weight-loss blockbuster tirzepatide, in comparison, is a relative late-comer, first reaching the U.S. market in 2022 as Mounjaro for type 2 diabetes Then in November 2023, the FDA approved the ...

RELATED: Eli Lilly launches higher doses of Zepbound, lowers price of certain vials Lilly also said they have "long been concerned" about counterfeit, compounded and any unapproved tirzepatide in the ...

Medicare coverage for anti-obesity drugs was not finalized, affecting drugs like Wegovy and Zepbound. Covering weight loss drugs may cost $35 billion from 2026–2034, with estimated savings under ...

Due to current legislation regarding weight loss drugs, Medicare Part D or Part C plans with drug coverage may only cover Zepbound for treating obstructive sleep apnea (OSA). However, the Centers ...

Zepbound (tirzepatide) is a brand-name subcutaneous (under the skin) injection that doctors initially prescribed for treating OSA. Since then, it has also gained approval for weight loss and ...